Article
Impact of programmed death-ligand 1 expression on the patients of stage IV non-small cell lung cancer harboring epidermal growth factor receptor mutation: a systematic review and meta-analysis.
Acta oncologica (Stockholm, Sweden) - 1 Dec 2020
Lee Chia Ching, Soon Yu Yang, Leong Cheng Nang, Koh Wee Yao, Tey Jeremy
Abstract excerpt
BACKGROUND: To determine the impact of programed death-ligand 1 (PD-L1) expression on progression-free survival (PFS) outcomes in stage IV epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) treated with first-line EGFR tyrosine kinase inhibitors (TKIs). MATERIAL AND METHODS: We searched biomedical databases for studies comparing PFS outcomes of PD-L1-positive versus (vs)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.